Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

CAMBRIDGE, MA: Takeda SVP and head of global communications João Belo has departed the company for a new opportunity. Belo announced his departure in a LinkedIn post on Wednesday, teasing his “next ...

"We are excited to see mezagitamab progress into Phase 3 trials, marking a significant step for Takeda and our n-CoDeR platform," said Martin Welschof, Chief Executive Officer of BioInvent.

"We are excited to see mezagitamab progress into Phase 3 trials, marking a significant step for Takeda and our n-CoDeR platform," said Martin Welschof, Chief Executive Officer of BioInvent.

"We are excited to see mezagitamab progress into Phase 3 trials, marking a significant step for Takeda and our n-CoDeR platform," said Martin Welschof, Chief Executive Officer of BioInvent. "This ...

H-E-B joined a lawsuit with Kroger, Albertsons and Walgreens against a pharmaceutical company over conspiring to delay the generic version of a drug. The companies hit Takeda and TWi Pharmaceuticals ...

The lawsuit obtained by MySA revealed that the retailers are accusing the pharmaceutical companies of conspiring to delay the release of the generic version of Takeda's heartburn medication ...

Takeda's AI-powered "returning to growth" program has improved profit margins, leading to upgraded FY2024 guidance and a JPY100 billion share buyback program. Takeda's Rusfertide and Protagonist's ...

Global biopharmaceutical company Takeda is committed to supporting Vietnam’s healthcare advancement by bringing life-transforming medicine and vaccines to the population. Benjamin Ping, the new ...

Artificial intelligence startup Scale AI is seeking a valuation as high as $25 billion in a potential tender offer as it looks to capitalize on the booming demand for the technology, Business ...